propranolol has been researched along with Experimental Mammary Neoplasms in 7 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The propranolol treatment (20 mg/kg body weight) started 12 days after MNU administration and lasted 10 weeks." | 1.62 | Chronic propranolol treatment moderately attenuated development of N-methyl-N-nitrosourea-induced mammary carcinoma in female rats. ( Cernackova, A; Horvathova, L; Macejova, D; Mravec, B; Tibensky, M; Tillinger, A, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Gurrapu, S | 1 |
| Jonnalagadda, SK | 1 |
| Alam, MA | 1 |
| Ronayne, CT | 1 |
| Nelson, GL | 1 |
| Solano, LN | 1 |
| Lueth, EA | 1 |
| Drewes, LR | 1 |
| Mereddy, VR | 1 |
| Tibensky, M | 1 |
| Cernackova, A | 1 |
| Horvathova, L | 1 |
| Macejova, D | 1 |
| Tillinger, A | 1 |
| Mravec, B | 1 |
| Campbell, JP | 1 |
| Karolak, MR | 1 |
| Ma, Y | 1 |
| Perrien, DS | 1 |
| Masood-Campbell, SK | 1 |
| Penner, NL | 1 |
| Munoz, SA | 1 |
| Zijlstra, A | 1 |
| Yang, X | 1 |
| Sterling, JA | 1 |
| Elefteriou, F | 1 |
| Cates, LA | 1 |
| Li, VS | 1 |
| Powell, DR | 1 |
| van der Helm, D | 1 |
| Shakhar, G | 1 |
| Ben-Eliyahu, S | 1 |
| Wickersham, JK | 1 |
| Barrett, WP | 1 |
| Furukawa, SB | 1 |
| Puffer, HW | 1 |
| Warner, NE | 1 |
| Schorr, I | 1 |
| Russell, A | 1 |
7 other studies available for propranolol and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents.
Topics: Animals; Antineoplastic Agents; Carboxylic Acids; Cell Line, Tumor; Cell Proliferation; Coumarins; D | 2016 |
Chronic propranolol treatment moderately attenuated development of N-methyl-N-nitrosourea-induced mammary carcinoma in female rats.
Topics: Adrenergic beta-Antagonists; Animals; Caspase 3; Dose-Response Relationship, Drug; Female; Gene Expr | 2021 |
Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice.
Topics: Adrenergic beta-Antagonists; Animals; Bone Marrow Cells; Bone Neoplasms; Cell Movement; Female; Mamm | 2012 |
Phosphorus-nitrogen compounds. 24. Phosphoramide mustard carrier derivatives.
Topics: Animals; Diethylstilbestrol; Dosage Forms; Ficusin; Leukemia, Experimental; Lung Neoplasms; Mammary | 1984 |
In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood-Brain Barrier; Cytotoxicity, I | 1998 |
An evaluation of the response of the microvasculature in tumors in C3H mice to vasoactive drugs.
Topics: Animals; Epinephrine; Isoproterenol; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Microc | 1977 |
Properties of adenylate cyclase of murine mammary carcinoma.
Topics: Adenylyl Cyclases; Animals; Epinephrine; Female; Fluorides; Hydrogen-Ion Concentration; Kinetics; La | 1974 |